2012), and even UV-C irradiation (95 % of substance left after 48 h) (Srinivasulu et al
Monitoring immediate response: Watch for injection site reactions (normal mild redness or slight swelling resolves within hours)
Quality-control risk Research-use peptide vials vary in purity, copper content, and reconstitution stability
conducted 12 weeks facial study of GHK-Cu containing face and eye cream, reporting significant improvement of skin laxity, clarity, and appearance, reduced fine lines and the depths of wrinkles, and increased skin density and thickness compared to placebo
It was tracked under the WADA Monitoring Program before being captured by the Prohibited List under Section S0 (Non-Approved Substances) and Section S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics)
May support chondrocyte function through general cellular health effects